D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 81 Citations 21,691 204 World Ranking 636 National Ranking 17
Medicine D-index 85 Citations 22,957 228 World Ranking 7631 National Ranking 232

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Immune system
  • Gene

The scientist’s investigation covers issues in Immunology, Immune system, Vaccination, Cancer and Antigen. His studies in Immunotherapy, T cell, CD8, Immunity and Epitope are all subfields of Immunology research. His Immune system research focuses on subjects like Proinflammatory cytokine, which are linked to Interleukin 5, Inflammasome and Innate immune system.

Sjoerd H. van der Burg has researched Vaccination in several fields, including Vulvar Diseases, Dendritic cell, Immunogenicity, Adjuvant and Nivolumab. Within one scientific family, Sjoerd H. van der Burg focuses on topics pertaining to Clinical trial under Cancer, and may sometimes address concerns connected to Alternative medicine. The various areas that Sjoerd H. van der Burg examines in his Antigen study include Efficacy, Oncolytic virus and Bioinformatics.

His most cited work include:

  • Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia (820 citations)
  • Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines (441 citations)
  • High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4 + T cells in human melanoma (439 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Immunology, Immune system, Immunotherapy, Cancer and Antigen. The study of Immunology is intertwined with the study of Cytotoxic T cell in a number of ways. His work carried out in the field of Cytotoxic T cell brings together such families of science as Epitope and Major histocompatibility complex.

His studies examine the connections between Immune system and genetics, as well as such issues in Cancer research, with regards to Antibody and Cancer cell. His research integrates issues of ELISPOT, Adoptive cell transfer, Immunogenicity and Peptide vaccine in his study of Immunotherapy. In his research on the topic of Cancer, Chemotherapy is strongly related with Oncology.

He most often published in these fields:

  • Immunology (54.77%)
  • Immune system (37.46%)
  • Immunotherapy (32.51%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (24.38%)
  • Immune system (37.46%)
  • Immunotherapy (32.51%)

In recent papers he was focusing on the following fields of study:

Sjoerd H. van der Burg mostly deals with Cancer research, Immune system, Immunotherapy, Cancer and Antigen. His Cancer research research is multidisciplinary, incorporating elements of Immune checkpoint, Cytotoxic T cell and Downregulation and upregulation. Immune system is the subject of his research, which falls under Immunology.

His Immunotherapy research integrates issues from Blockade, CD8, Pancreatic cancer and Adenocarcinoma. His biological study spans a wide range of topics, including Clinical efficacy and Immunosuppression. His studies in Antigen integrate themes in fields like Serology and Bioinformatics.

Between 2018 and 2021, his most popular works were:

  • Actively personalized vaccination trial for newly diagnosed glioblastoma (249 citations)
  • Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial. (137 citations)
  • Monalizumab: inhibiting the novel immune checkpoint NKG2A (42 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Immune system
  • Gene

His primary areas of study are Immune system, Cancer research, T cell, Cytotoxic T cell and Cancer. His Immune system research includes elements of Myeloid and Vaccination. His work in Cancer research tackles topics such as Antigen which are related to areas like Cancer cell.

His T cell study combines topics in areas such as CD8 and Immunotherapy. In his research, Clinical trial is intimately related to Oncology, which falls under the overarching field of Cancer. His Cancer immunotherapy study is focused on Immunology in general.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

Gemma G Kenter;Marij J P Welters;A Rob P M Valentijn;Margriet J G Lowik.
The New England Journal of Medicine (2009)

977 Citations

Comprehensive control of human papillomavirus infections and related diseases.

F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki.
Vaccine (2013)

603 Citations

Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines

Cornelis J.M. Melief;Sjoerd H. van der Burg.
Nature Reviews Cancer (2008)

579 Citations

Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides

Sander Zwaveling;Sandra C. Ferreira Mota;Jan Nouta;Mark Johnson.
Journal of Immunology (2002)

505 Citations

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4 + T cells in human melanoma

Carsten Linnemann;Marit M van Buuren;Laura Bies;Els M E Verdegaal.
Nature Medicine (2015)

478 Citations

Identification and manipulation of tumor associated macrophages in human cancers

Moniek Heusinkveld;Sjoerd H van der Burg.
Journal of Translational Medicine (2011)

474 Citations

A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence

Joanna Kaplon;Liang Zheng;Katrin Meissl;Barbara Chaneton.
Nature (2013)

462 Citations

Vaccines for established cancer: overcoming the challenges posed by immune evasion.

Sjoerd H. van der Burg;Ramon Arens;Ferry Ossendorp;Thorbald van Hall.
Nature Reviews Cancer (2016)

462 Citations

Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.

Marij J P Welters;Gemma G Kenter;Sytse J Piersma;Annelies P G Vloon.
Clinical Cancer Research (2008)

456 Citations

Therapeutic cancer vaccines

Cornelis J.M. Melief;Thorbald van Hall;Ramon Arens;Ferry Ossendorp.
Journal of Clinical Investigation (2015)

442 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sjoerd H. van der Burg

Cornelis J. M. Melief

Cornelis J. M. Melief

Leiden University Medical Center

Publications: 77

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 68

Ferry Ossendorp

Ferry Ossendorp

Leiden University Medical Center

Publications: 63

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 61

Ekaterina S. Jordanova

Ekaterina S. Jordanova

Vrije Universiteit Amsterdam

Publications: 55

W. Martin Kast

W. Martin Kast

University of Southern California

Publications: 52

George Coukos

George Coukos

University of Lausanne

Publications: 50

Laurence Zitvogel

Laurence Zitvogel

Institut Gustave Roussy

Publications: 48

Hans-Georg Rammensee

Hans-Georg Rammensee

University of Tübingen

Publications: 48

Chien-Fu Hung

Chien-Fu Hung

Johns Hopkins University

Publications: 45

Richard B.S. Roden

Richard B.S. Roden

Johns Hopkins University

Publications: 42

Stefan Stevanovic

Stefan Stevanovic

University of Tübingen

Publications: 39

Jérôme Galon

Jérôme Galon

Université Paris Cité

Publications: 38

Ian H. Frazer

Ian H. Frazer

University of Queensland

Publications: 38

Jeffrey Schlom

Jeffrey Schlom

National Institutes of Health

Publications: 38

Jan W. Drijfhout

Jan W. Drijfhout

Leiden University Medical Center

Publications: 37

Trending Scientists

Weifa Liang

Weifa Liang

City University of Hong Kong

Raquel Fernandez

Raquel Fernandez

New York University

Hal L. Smith

Hal L. Smith

Arizona State University

Mattias Beck

Mattias Beck

ETH Zurich

Jae-Young Je

Jae-Young Je

Pukyong National University

Clare E. Futter

Clare E. Futter

University College London

Luigi Franchi

Luigi Franchi

University of Michigan–Ann Arbor

Gera Neufeld

Gera Neufeld

Technion – Israel Institute of Technology

Shigetou Namba

Shigetou Namba

University of Tokyo

Jonathan M. Schapiro

Jonathan M. Schapiro

Sheba Medical Center

Mark Mulligan

Mark Mulligan

King's College London

Philippe Ryvlin

Philippe Ryvlin

University Hospital of Lausanne

Jacqueline V. Lerner

Jacqueline V. Lerner

Boston College

Ingrid Melle

Ingrid Melle

Oslo University Hospital

Weiya Zhang

Weiya Zhang

University of Nottingham

Yvonne Elsworth

Yvonne Elsworth

University of Birmingham

Something went wrong. Please try again later.